Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01929057 · ClinicalTrials.gov registry record

Evaluation of the Role of Propionibacterium Acnes in the Inflammatory Lesions Associated With Acne Vulgaris

A clinical trial, sponsored by University of California, San Diego.

Completed
Registry status
34
Enrollment target

NCT01929057 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 34 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01929057 has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
34 participants
Enrollment target

Study Summary

The purpose of this study is to determine the response of acne patients and healthy control patients to the P. acnes bacteria. Half a tube of blood will be drawn from all participants to determine whether or not they have antibodies to the P. acnes bacterium. Anywhere from 1 to 4 skin biopsies of acne pimples or normal control skin will be taken from all subjects for further analysis in the lab to determine whether the inflammation in these pimples can be reduced using anti-P.acnes antibodies.

Interventions

  • PROCEDURE Blood draw
  • PROCEDURE Skin biopsy

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2013-08
Est. Completion 2014-06

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT01929057

The ClinicalTrials.gov registry entry for NCT01929057 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Blood draw is the first listed.

NCT01929057 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01929057 about?

NCT01929057 is a clinical study titled "Evaluation of the Role of Propionibacterium Acnes in the Inflammatory Lesions Associated With Acne Vulgaris". The purpose of this study is to determine the response of acne patients and healthy control patients to the P. acnes bacteria. Half a tube of blood will be drawn from all participants to determine whether or not they have antibodies to the P. acnes bacterium. Anywhere from 1 to 4 skin biopsies of ac...

What is the current status of trial NCT01929057?

This trial is currently completed. The enrollment target is 34 participants. The study started on 2013-08. Estimated completion is 2014-06.

What interventions are being tested in trial NCT01929057?

The interventions under investigation include: Blood draw (PROCEDURE), Skin biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT01929057?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.